Techno-economic evaluation of GHG emissions mitigation of biomethane upgrading technologies.

The current trend in the European biogas industry is to shift away from electricity production towards the production of biomethane for the need to replace natural gas. The upgrading of biogas to biomethane is normally performed by separating the biogas in a stream containing natural gas grid quality methane and a stream containing mostly CO2. The CO2 stream is normally released into the atmosphere; however, part of the methane may still remain in it, and, if not oxidized, even a small fraction of methane released may jeopardise all the GHG emissions savings from producing the biomethane, being methane a powerful climate forcer. Scope of this work is to assess the opportunity cost of installing an Off Gas Combustion (OGC) device in biomethane upgrading plants. The currently available technologies for biogas upgrading to biomethane and the most common technology of OGC (the Regenerative Thermal Oxidisers, RTO) are described according to their performances and cost. Then the cost per tonne of CO2eq avoided associated to the adoption of RTO systems in relation to the upgrading performance is calculated to identify a potential threshold for an effective and efficient application of the RTO systems. It is found that, in case of upgrading technologies which can capture almost all biomethane in the upgrading off-gas (i.e. 99.9%), currently the adoption of an RTO to oxidise the methane left in the off-gas would add costs and need additional fuel to be operated, but would generate limited GHG emission savings, therefore the cost per tonne of CO2eq emissions avoided would result not competitive with other GHG emissions mitigation investments. While the installation of RTOs on upgrading systems with a methane slip of 0.3%, or higher, normally results cost competitive in reducing GHG emissions. The installation of an RTO on systems with a methane slip of 0.2% results in a cost per tonne of CO2eq emissions avoided of 50-100 euro, which is comparable to the current cost of CO2 emissions allowances in the EU ETS carbon market, representing therefore a reasonable choice for a threshold on methane slip regulation for biogas upgrading systems.

Reliability of Domestic Gas Flow Sensors with Hydrogen Admixtures.

Static flow sensors (e.g., thermal gas micro electro-mechanical sensors-MEMS-and ultrasonic time of flight) are becoming the prevailing technology for domestic gas metering and billing since they show advantages in respect to the traditional volumetric ones. However, they are expected to be influenced in-service by changes in gas composition, which in the future could be more frequent due to the spread of hydrogen admixtures in gas networks. In this paper, the authors present the results of an experimental campaign aimed at analyzing the in-service reliability of both static and volumetric gas meters with different hydrogen admixtures. The results show that the accuracy of volumetric and ultrasonic meters is always within the admitted limits for subsequent verification and even within those narrower of the initial verification. On the other hand, the accuracy of the first generation of thermal mass gas flow sensors is within the limits of the verification only when the hydrogen admixture is below 2%vol. At higher hydrogen content, in fact, the absolute weighted mean error ranges between 3.5% (with 5%vol of hydrogen) and 15.8% (with 10%vol of hydrogen).

Inflammatory status in pediatric sickle cell disease: Unravelling the role of immune cell subsets.

Introduction: The mutation of the beta-globin gene that causes sickle cell disease (SCD) results in pleiotropic effects, such as hemolysis and vaso-occlusive crisis that can induce inflammatory mechanisms with deleterious consequences on the organism. Moreover, SCD patients display an increased susceptibility to infections. Few studies are currently available that evaluate a wide immunological profile in a pediatric population. This study proposes an evaluation of the immune profile in subjects with SCD in a pediatric population through a detailed analysis by flow cytometry. Methods and Materials: Peripheral blood samples from 53 pediatric patients with SCD (mean age 9.8 years, interquartile range 9 years) were obtained and then analyzed by flow cytometry, in order to evaluate changes in the immune populations compared to 40 healthy donors (mean age 7.3 years, interquartile range 9.5 years). Results: Our data showed an increase in neutrophils (with a reduction in the CD62L + subpopulation) and monocytes (with a decrease in HLA-DRlow monocytes) with normal values of lymphocytes in SCD patients. In the lymphocyte subpopulations analysis we observed lower values of CD4+ T cells (with higher number of memory and central memory T lymphocytes) with increased frequency of CD8+ T cells (with a predominant naive pattern). Moreover, we observed higher values of CD39+ Tregs and lower HLA-DR+ and CD39- T cells with an increased Th17, Th1-17 and Th2 response. Conclusion: We observed immunological alterations typical of an inflammatory status (increase in activated neutrophils and monocytes) associated with a peculiar Treg pattern (probably linked to a body attempt to minimize inflammation intrinsic to SCD). Furthermore, we highlighted a T helper pathway associated with inflammation in line with other studies. Our data showed that immunological markers may have an important role in the understanding the pathophysiology of SCD and in optimizing targeted therapeutic strategies for each patient.